August 22, 2004

New Cancer Drug for Pleural Mesothelioma

A new treatment for asbestos-related lung cancer has been registered for use in New Zealand.

Alimta (Pemetrexed) has been shown to extend the life expectancy of patients with malignant pleural mesothelioma an average of 12 months, compared with six to eight months on existing treatments. (New Zealand Herald)

Talk about this story

Remember Me?

Related Stories

More News Topics:
Breast Cancer      Alternative Medicine      Infectious Disease       Eating Disorders       Sleep      Orthopedic      Allergies      Neurological Disorders      Chronic Pain       Senior Health       Heart Health      Mental Health       Autoimmune Disorders       Women's Health
All content published on is provided for informational and educational purposes only. does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your health routine or treatment.

Copyright © 2004-2005 All rights reserved.